期刊文献+

三阴乳腺癌患者的临床病理特征及预后情况分析 被引量:7

Clinicopathological Characteristics and Prognosis Analysis of Patients with TNBC
下载PDF
导出
摘要 目的探讨三阴乳腺癌(triple negative breast cancer,TNBC)患者的临床病理特征及预后情况。方法选取2009年7月—2011年7月收治的360例乳腺癌患者的病例资料,按免疫组织化学检测结果分为非三阴性乳腺癌(nTNBC)组和TNBC组,每组180例。比较两组的临床病理资料,从而对TNBC组临床病理特征及预后情况进行分析。结果两组患者的发病年龄、临床分期、肿瘤病灶直径、淋巴结转移和组织学分级比较差异具有统计意义(P<0.01,P<0.05)。TNBC组局部复发率和远端转移率高于nTNBC组(P<0.01,P<0.05)。TNBC组无病生存率和总生存率均低于nTNBC组(P<0.05)。结论 TNBC多见于50岁以上的女性,肿瘤分化差、恶性程度高,患者手术预后效果不佳,死亡率较其他类型乳腺癌疾病高。 Objective To investigate clinicopathological characteristics and prognosis of patients with triple negative breast cancer (TNBC). Methods Clinical data of 360 patients with TNBC admitted during July 2009 and July 2011 was recruited in these study, and the patients were divided into non-TNBC group (nTNBC group, n = 180) and TNBC group (n = 180) according to immunohistochemistry resuhs. Clinicopathological characteristics of the two groups were compared, and clinicopathological characteristics and prognosis of TNBC were analyzed. Results There were significant differences in age of onset, clinical stage, tumor diameter, lymph node metastasis and histological grade in two groups (P 〈 0.01, P 〈 0.05). Local recurrence and distant metastasis rates in TNBC group were significantly higher than those in nTNBC group ( P 〈 0. 01, P 〈 0. 05). The disease-free survival and overall survival rates in TNBC group were significantly lower than those in nTNBC group (P 〈 0.05). Conclusion TNBC is more common in women over 50 years old with characteristics such as poor tumor differentiation, high malignancy degree and poor prognosis, and its mortality rate is higher than other types of breast cancer.
出处 《解放军医药杂志》 CAS 2017年第3期39-41,共3页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
关键词 三阴性乳腺癌 受体 表皮生长因子 预后 Triple negative breast cancer Receptor, epidermal growth factor Prognosis
  • 相关文献

参考文献14

二级参考文献197

  • 1姜丽娜,于世英,熊慧华,张孟贤.胸苷磷酸化酶在癌组织中表达的研究[J].中华肿瘤杂志,2004,26(5):297-299. 被引量:72
  • 2万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1253
  • 3Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers intriple-negative breast cancer[J].Cancer,2007,109:25-32.
  • 4Morris GJ,Naidu S,Topham AK,et al.Differences in breastcarcinoma characteristics in newly diagnosed african-americanand caucasian patients:a single-institution compilation comparedwith the national cancer institute's surveillance,epidemiology,and end results database[J].Cancer,2007,110:876-884.
  • 5Reis-Filho JS,Tutt AN.Triple negative tumours:a critical re-view[J].Histopathology,2008,52:108-118.
  • 6Kim MJ,Ro JY,Ahn SH,et al.Clinicopathologic significance ofthe basal-like subtype of breast cancer:a comparison with hor-mone receptor and Her2/neu-overexpressing phenotypes[J].Hum Pathol,2006,37:1217-1226.
  • 7Sasa M,Bando Y,Takahashi M,et al.Screening for basalmarker expression is necessary for decision of therapeutic strategyfor triple-negative breast cancer[J].J Surg Oncol,2008,97:30-34.
  • 8Tischkowitz M,Brunet JS,Bégin LR et al.Use of immunohisto-chemical markers can refine prognosis in triple negative breastcancer[J].BMC Cancer,2007,7:134.
  • 9Dent R,Hanna WM,Trudeau M,et al.Pattern of metastaticspread in triple-negative breast cancer[J].Breast Cancer ResTreat,2009,115:423-428.
  • 10Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breastcancer:clinical features and patterns of recurrence[J].ClinCancer Res,2007,13:4429-4434.

共引文献138

同被引文献57

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部